Fuji Pharma: Announcement of changes in the representative director.
Fuji Pharma: Confirmation letter
Fuji Pharma: Quarterly Report - 60th Quarter 2 (2024/01/01 to 2024/03/31)
Fuji Pharma: Notice regarding differences between second-quarter earnings forecasts and actual results and partial revisions to full-year earnings forecasts
Fuji Pharma: Summary of Financial Results for the 2nd Quarter of the Fiscal Year Ending 2024/9 [Japanese GAAP] (Consolidated)
Fuji Pharma: Change Report
Fuji Pharmaceutical Industries: Confirmation
Fuji Pharmaceutical Industries: Quarterly Report - First quarter of the 60th term (2023/10/01 - 2023/12/31)
Fuji Pharma: Summary of Financial Results for the 1st Quarter Ending 2024/9 [Japanese GAAP] (Consolidated)
Fuji Pharma: Succession of manufacturing and sales approval for 3 products from Mitsubishi Tanabe Pharma to Fuji Pharmaceutical
Fuji Pharma: Report on Corporate Governance 2023/12/21
Fuji Pharma: Extraordinary Report
Fuji Pharma: Confirmation letter
Fuji Pharma: Internal Control Report - Period 59 (2022/10/01 - 2023/09/30)
Fuji Pharma: Securities Report — The 59th Term (2022/10/01 - 2023/09/30)
Fuji Pharma: Notice of the 59th Ordinary General Meeting of Shareholders
Fuji Pharma: Notice of convocation of the Annual General Meeting of Shareholders for the fiscal year ending 2023/9 (59 terms)
Fuji Pharma: Notice Concerning Recording of Gains on Sale of Investment Securities (Extraordinary Profit) and Revision of Earnings Forecasts
Fuji Pharma: (Correction) Partial correction relating to the summary of financial results for the fiscal year ending 2023/9 [Japanese GAAP] (consolidated)
Fuji Pharma: Brief Financial Report for the Fiscal Year Ending September 2023 [Japanese GAAP] (Consolidated)
No Data